What is the dose equivalent of 20 mg Adderall XR (mixed amphetamine salts) in Metadate (methylphenidate)?

Dose Conversion: Adderall XR 20mg to Metadate

There is no established fixed dose conversion ratio between Adderall XR (mixed amphetamine salts) and Metadate (methylphenidate), but based on clinical practice guidelines, a reasonable starting equivalent would be approximately 30-40 mg of methylphenidate extended-release formulations.

Rationale for Conversion

The lack of a standardized conversion stems from fundamental pharmacological differences between these medications:

• Starting dose recommendations from AACAP guidelines indicate methylphenidate (MPH) begins at 5 mg while amphetamine/dextroamphetamine (AMP/DEX) begins at 2.5 mg, suggesting a roughly 2:1 ratio 11
• Maximum daily doses are listed as 60 mg for MPH versus 40 mg for amphetamines, again suggesting approximately a 1.5:1 ratio 1
• Clinical potency differences from comparative research show that lower doses of Adderall produce effects comparable to higher doses of methylphenidate 23

Practical Conversion Approach

For Adderall XR 20 mg, consider starting with:

• Metadate CD or ER: 30-40 mg once daily as the initial equivalent dose
• This represents a conservative 1.5-2:1 conversion ratio (MPH:AMP)

Important Caveats

Individual response varies significantly - research demonstrates that approximately 43% of patients show preferential response to one stimulant class over another 4. The conversion is not simply mathematical but requires clinical titration.

Duration of action differs - Adderall XR provides comparable plasma concentrations to immediate-release Adderall 10 mg given twice daily (4 hours apart) 55. Metadate formulations have different release profiles that may not perfectly match this pattern.

Titration Strategy After Conversion

Rather than relying solely on theoretical equivalence, follow this systematic approach 1:

1. Start with the estimated equivalent dose (30-40 mg Metadate)
2. Assess response weekly using standardized rating scales from teachers and parents
3. Adjust in 5-10 mg increments of methylphenidate if symptom control is inadequate
4. Monitor for adverse effects - appetite suppression, insomnia, irritability
5. Consider that 70% respond to either medication alone, but nearly 90% respond if both classes are tried 1

Monitoring Parameters

• ADHD symptom ratings from multiple sources (teacher, parent, self-report if age-appropriate)
• Blood pressure and pulse at each adjustment
• Height and weight to track growth
• Sleep quality and appetite
• Behavioral side effects (anxiety, irritability, tics)

Clinical Decision Points

If inadequate response at 40 mg Metadate:

• Increase to maximum of 60 mg total daily dose 1
• Consider that more is not necessarily better - lack of response may indicate need for alternative medication class or psychosocial intervention 1

If excessive side effects occur:

• Reduce dose by 5-10 mg increments
• Consider switching back to amphetamine-based formulation
• Evaluate timing of administration relative to meals (food delays Tmax by ~2 hours but doesn't affect total absorption) 5

The evidence consistently shows both medication classes are effective, but individual patient response cannot be predicted from dose equivalence calculations alone 42. Clinical titration based on symptom response and tolerability remains the gold standard approach 16.